Christopher Von Seggern

Christopher Von Seggern

Chief Commercial OfficeratXenon Pharmaceuticals· In proxies 2022–2024

Pay in FY2022Xenon Pharmaceuticals stock +26.2% the same year

Christopher Von Seggern was paid $2.7M in FY2022 (Dec). Xenon Pharmaceuticals stock rose 26.2% that year.

Pay$100 in the stock at the end of FY21 → $126
Pay is from the Summary Compensation Table of each Xenon Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Xenon PharmaceuticalsPublic company · 4 yr
    • Chief Commercial Officer2022 – Present · 4 yrStock in role +16%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?